We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current MRK market cap is 225.85B. The company's latest EPS is USD 0.1443 and P/E is 620.24.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 15.96B | 14.63B | 15.78B | 16.11B | 16.66B |
| Operating Income | 5.75B | -1.97B | 5.64B | 6.05B | 3.93B |
| Net Income | 4.75B | -1.23B | 4.76B | 5.46B | 3.16B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 46.84B | 47.99B | 48.7B | 59.28B | 60.12B |
| Operating Income | 11.6B | 7.91B | 12.54B | 17.95B | 2.36B |
| Net Income | 9.71B | 7.07B | 13.05B | 14.52B | 365M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 106.73B | 106.68B | 105.85B | 112.63B | 117.53B |
| Total Liabilities | 65.43B | 69.04B | 65.43B | 68.98B | 72.97B |
| Total Equity | 41.3B | 37.64B | 40.42B | 43.65B | 44.56B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 84.4B | 91.59B | 105.69B | 109.16B | 106.68B |
| Total Liabilities | 58.4B | 66.18B | 67.44B | 63.1B | 69.04B |
| Total Equity | 26B | 25.4B | 38.26B | 46.06B | 37.64B |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 12.76B | 13.01B | 3.09B | 8.73B | 18.02B |
| Investing | -14.14B | -14.08B | -1.38B | -2.45B | -6.29B |
| Financing | -2.57B | -4.81B | -2.81B | -1.6B | -4.02B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 13.44B | 10.25B | 14.11B | 19.1B | 13.01B |
| Investing | -2.63B | -9.44B | -16.56B | -4.96B | -14.08B |
| Financing | -8.86B | -2.83B | 2.59B | -9.12B | -4.81B |
| Market Cap | 225.85B |
| Price to Earnings Ratio | 620.24 |
| Price to Sales Ratio | 3.77 |
| Price to Cash Ratio | 33.1 |
| Price to Book Ratio | 6.02 |
| Dividend Yield | 3.63% |
| Shares Outstanding | 2.53B |
| Average Volume (1 week) | 21.24M |
| Average Volume (1 Month) | 18.66M |
| 52 Week Change | -29.89% |
| 52 Week High | 134.63 |
| 52 Week Low | 81.04 |
| Spread (Intraday) | 0.09 (0.1%) |
| Company Name | Merck and Co Inc |
| Address |
820 bear tavern road west trenton, new jersey 08628 1021 |
| Website | https://www.merck.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
